EP2010528A2
6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
Abstract
This record has no abstract on file.
Term
0.6 yearsto projected expiry
Projected expiry 18 April 2027, counted from filing; an application has no term until it is granted.
- Priority and filed
- Published
- Today
- Projected expiry
47 members in 32 offices
Members47
| Document | Office | Kind | |
|---|---|---|---|
| AU2007237904A1 | Australia | A1 | |
| CA2649288A1 | Canada | A1 | |
| WO2007121484A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007121484A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2008045528A1 | United States of America | A1 | |
| TW200813039A | Taiwan Province of China | A | |
| PE20080359A1 | Peru | A1 | |
| AR060545A1 | Argentina | A1 | |
| MX2008013427A | Mexico | A | |
| NO20084800L | Norway | L | |
| SMAP200800063A | San Marino | A | |
| ECSP088830A | Ecuador | A | |
| KR20080112388A | Republic of Korea | A | |
| CR10365A | Costa Rica | A | |
| EP2010528A2This record | European Patent Office (EPO) | A2 | |
| EA200802129A1 | Eurasian Patent Organization (EAPO) | A1 | |
| MA30407B1 | Morocco | B1 | |
| CN101432281A | China | A | |
| ZA200808105B | South Africa | B | |
| US7553854B2 | United States of America | B2 | |
| IL194662D0 | Israel | D0 | |
| JP2009534410A | Japan | A | |
| SMP200800063B | San Marino | B | |
| TNSN08406A1 | Tunisia | A1 | |
| US2010280006A1 | United States of America | A1 | |
| AU2007237904B2 | Australia | B2 | |
| BRPI0710540A2 | Brazil | A2 | |
| US8173689B2 | United States of America | B2 | |
| US2012225861A1 | United States of America | A1 | |
| CN101432281B | China | B | |
| JP5328640B2 | Japan | B2 | |
| EA018917B1 | Eurasian Patent Organization (EAPO) | B1 | |
| US8710048B2 | United States of America | B2 | |
| KR101464385B1 | Republic of Korea | B1 | |
| CA2649288C | Canada | C | |
| EP2010528B1 | European Patent Office (EPO) | B1 | |
| PT2010528T | Portugal | T | |
| LT2010528T | Lithuania | T | |
| DK2010528T3 | Denmark | T3 | |
| HRP20171924T1 | Croatia | T1 | |
| ES2654847T3 | Spain | T3 | |
| RS56600B1 | Serbia | B1 | |
| SI2010528T1 | Slovenia | T1 | |
| PL2010528T3 | Poland | T3 | |
| CY1119679T1 | Cyprus | T1 | |
| HUE035654T2 | Hungary | T2 | |
| BRPI0710540B1 | Brazil | B1 |
121 legal events, as 21 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapse because of not paying annual feesLapsedMM01 | MM01 | AT | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsed due to non-payment of maintenance feesLapsedMM4A | MM4A | SK | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | NL | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| Ip right lapsedLapsedST27 STATUS EVENT CODE: U-0-0-H10-H13 (AS PROVIDED BY THE NATIONAL OFFICE)H13 | H13 | CH | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Lapse european patentLapsedMM4D | MM4D | LT | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapse due to non-payment of renewal feeLapsedPBON | PBON | HR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Publication of translation of european patent specificationUEP | UEP | AT | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Ep patent validated in greeceEP | EP | GR | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Translation of european patent specification into slovakT3 | T3 | SK | |
| Fee paymentPLFP | PLFP | FR | |
| Definitive protectionFG2A | FG2A | ES | |
| Translation of the specification of european patent valid in estoniaFG4A | FG4A | EE | |
| Ep patent validated in croatiaT1PR | T1PR | HR | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Request for ep validation receivedTUEP | TUEP | HR | |
| Ep patent valid in romaniaEPE | EPE | RO | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE |
Showing 100 of 121
Numbers
- Publication
- 2010528
- Application
- 77972446
Titles3
- German
- 6-O-SUBSTITUIERTE BENZOXAZOL- UND BENZOTHIAZOLVERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON CSF-1R-SIGNALISIERUNG
- English
- 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING
- French
- COMPOSÉS À BASE DE BENZOXAZOLE ET DE BENZOTHIAZOLE 6-0 SUBSTITUÉS ET PROCÉDÉS D'INHIBITION DE SIGNALISATION CSF-1R
Classification
- CPC, 12
- C07D413/12
- C07D417/12
- A61P13/12
- A61P19/00
- A61P19/02
- A61P19/10
- A61P29/00
- A61P35/00
- A61P35/02
- A61P43/00
- A61P9/10
- A61K31/44
- IPC, 6
- C07D413 12
- C07D417 12
- A61K31 44
- A61P35 00
- A61P19 02
- A61P19 10
Designated states37
- Contracting states, 32
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Malta
and 8 moreShow fewer
- Netherlands (Kingdom of the)
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 5
- Albania
- Bosnia and Herzegovina
- Croatia
- North Macedonia
- Serbia